Ying Yang
Ying Yang publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Immunotherapy and Immune Responses.
- World rank
- #2,277,250 of 7,710,434 ranked researchers
- Rank in China
- #353,965 of 978,568
- Works
- 73
- Citations
- 1.1k
- Citations per work
- 15.7
What does Ying Yang research?
Ying Yang's work is mostly in Medicine (49%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3649.3%
- Medicine3649.3%
- Everything else2838.8%
- Life Sciences911.9%
- 1Oncology22% of their works
- 2Pulmonary and Respiratory Medicine19% of their works
- 3Immunology8% of their works
- 4Surgery4% of their works
- 5Cancer Research4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
Which keywords describe Ying Yang's research?
The keywords of their largest research topics: Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations and Cancer.
- Dosimetry
- Molecular Characterization
- Cancer Genomics
- Genomic Profiles
- Ferroptosis
- Cancer
- ALK Inhibitors
- Targeted Therapy
- Immune Checkpoint Blockade
- Tumor Microenvironment
- PD-1 and PD-L1
- Clinical Trials
- EGFR Mutations
- Dendritic Cells
- Immunity
- Small-Cell Lung Cancer
- Microsatellite Instability
- Mutational Signatures
- Radiotherapy Physics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Tumor Microenvironment302 topics
- Immune Checkpoint Blockade231 topic
- PD-1 and PD-L1231 topic
- Targeted Therapy223 topics
- Clinical Trials172 topics
- ALK Inhibitors111 topic
- EGFR Mutations111 topic
- Cancer71 topic
- Dendritic Cells71 topic
- Ferroptosis71 topic
- Immunity71 topic
- Genomic Profiles61 topic
- Small-Cell Lung Cancer61 topic
- Cancer Genomics51 topic
- Microsatellite Instability51 topic
- Molecular Characterization51 topic
- Mutational Signatures51 topic
- Dosimetry41 topic
- Radiotherapy Physics41 topic
Where does Ying Yang work?
Ying Yang's main affiliation in the publication record is Genecast (China), China.
How many publications and citations does Ying Yang have?
OpenAlex counts 73 works and 1,149 citations for Ying Yang, an h-index of 18, ranking #2,277,250 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ying Yang
- ying-yang-chinese-academy-of-sciences
- ying-yang-chinese-academy-of-medical-sciences-and-peking-union-medical-college
- ying-yang-university-of-st-andrews
- ying-yang-the-university-of-texas-md-anderson-cancer-center
- ying-yang-huazhong-university-of-science-and-technology
- ying-yang-oak-ridge-national-laboratory
- ying-yang-peking-university-china-3
- ying-yang-tsinghua-university
- ying-yang-changchun-university-of-science-and-technology
- ying-yang-keele-university
- ying-yang-center-for-devices-and-radiological-health
- ying-yang-china-agricultural-university
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ying Yang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.